JP Morgan Chase’s Bio-Path Holdings BPTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-217
| Closed | -$252 | – | 7911 |
|
|
2024
Q4 | $252 | Buy |
+217
| New | +$202 | ﹤0.01% | 6897 |
|
|
2023
Q3 | – | Sell |
-22
| Closed | -$306 | – | 7421 |
|
|
2023
Q2 | $766 | Sell |
22
-1
| -4% | -$31 | ﹤0.01% | 6508 |
|
|
2023
Q1 | $1K | Buy |
+23
| New | +$828 | ﹤0.01% | 6599 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 5830 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 5977 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 6053 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 6102 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 6135 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 6018 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 5909 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 5764 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 5711 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 5645 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 4950 |
|
|
2017
Q2 | – | Sell |
-15
| Closed | -$31.5K | – | 4922 |
|
|
2017
Q1 | $49K | Sell |
15
-15
| -50% | -$54.5K | ﹤0.01% | 4561 |
|
|
2016
Q4 | $163K | Buy |
+30
| New | +$145K | ﹤0.01% | 4264 |
|
|
2015
Q3 | – | Sell |
-4
| Closed | -$18K | – | 4156 |
|
|
2015
Q2 | $18K | Buy |
+4
| New | +$21.9K | ﹤0.01% | 3979 |
|
Other funds holding BPTH
JP Morgan Chase's BPTH Position: Q1 2025 in Review
JP Morgan Chase sold out of Bio-Path Holdings (BPTH) in Q1 2025, closing a stake of 217 shares — an estimated $252 sold.
JP Morgan Chase first reported a position in BPTH in Q2 2015 and held it in 6 quarters. The position peaked at $163K in Q4 2016. 2 funds tracked by Wall St. Rank hold BPTH as of Q1 2025.
- JP Morgan Chase reported no remaining Bio-Path Holdings position as of Q1 2025 after selling out during the quarter.
- JP Morgan Chase sold 217 Bio-Path Holdings shares in Q1 2025, an estimated $252.
- JP Morgan Chase first reported a position in Bio-Path Holdings in Q2 2015 and held it in 6 quarters.
- JP Morgan Chase's Bio-Path Holdings position peaked at $163K in Q4 2016.
- 2 funds tracked by Wall St. Rank held Bio-Path Holdings as of Q1 2025.
Based on JP Morgan Chase's 13F filing for Q1 2025, filed 12 May 2025.